

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 7.55496724 |
| 2 | nuclear pore organization (GO:0006999) | 6.66489659 |
| 3 | pore complex assembly (GO:0046931) | 5.44605732 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.01297518 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.01297518 |
| 6 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96367493 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.85565475 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 4.83756403 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.83756403 |
| 10 | lysine catabolic process (GO:0006554) | 4.75155368 |
| 11 | lysine metabolic process (GO:0006553) | 4.75155368 |
| 12 | tryptophan catabolic process (GO:0006569) | 4.68055312 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 4.68055312 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 4.68055312 |
| 15 | regulation of RNA export from nucleus (GO:0046831) | 4.57615696 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 4.56859333 |
| 17 | COPI coating of Golgi vesicle (GO:0048205) | 4.56859333 |
| 18 | complement activation, alternative pathway (GO:0006957) | 4.45554147 |
| 19 | glyoxylate metabolic process (GO:0046487) | 4.44024153 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.42405859 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 4.41820571 |
| 22 | kynurenine metabolic process (GO:0070189) | 4.38470864 |
| 23 | cysteine metabolic process (GO:0006534) | 4.38210787 |
| 24 | regulation of protein activation cascade (GO:2000257) | 4.18681376 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.13548937 |
| 26 | mitotic chromosome condensation (GO:0007076) | 4.13533215 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 4.12892812 |
| 28 | sister chromatid segregation (GO:0000819) | 4.11190132 |
| 29 | DNA unwinding involved in DNA replication (GO:0006268) | 4.09750072 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.09279514 |
| 31 | formation of translation preinitiation complex (GO:0001731) | 4.09167933 |
| 32 | urea metabolic process (GO:0019627) | 4.06806095 |
| 33 | urea cycle (GO:0000050) | 4.06806095 |
| 34 | regulation of complement activation (GO:0030449) | 4.05075483 |
| 35 | mitotic sister chromatid segregation (GO:0000070) | 4.03137236 |
| 36 | protein carboxylation (GO:0018214) | 4.01153851 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.01153851 |
| 38 | sulfur amino acid catabolic process (GO:0000098) | 3.99433579 |
| 39 | valine metabolic process (GO:0006573) | 3.97980071 |
| 40 | bile acid biosynthetic process (GO:0006699) | 3.97626685 |
| 41 | mitotic nuclear envelope disassembly (GO:0007077) | 3.89363183 |
| 42 | urate metabolic process (GO:0046415) | 3.89120722 |
| 43 | nitrogen cycle metabolic process (GO:0071941) | 3.78385220 |
| 44 | fatty acid beta-oxidation (GO:0006635) | 3.76157430 |
| 45 | COPII vesicle coating (GO:0048208) | 3.74369335 |
| 46 | regulation of mitotic spindle organization (GO:0060236) | 3.73562118 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 3.72601440 |
| 48 | ethanol oxidation (GO:0006069) | 3.72150522 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.71487362 |
| 50 | DNA topological change (GO:0006265) | 3.68847224 |
| 51 | nuclear envelope disassembly (GO:0051081) | 3.68452999 |
| 52 | membrane disassembly (GO:0030397) | 3.68452999 |
| 53 | fatty acid oxidation (GO:0019395) | 3.66651550 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 3.64093651 |
| 55 | regulation of centriole replication (GO:0046599) | 3.62581355 |
| 56 | lipid oxidation (GO:0034440) | 3.62424068 |
| 57 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.56877073 |
| 58 | carnitine metabolic process (GO:0009437) | 3.56676413 |
| 59 | drug transmembrane transport (GO:0006855) | 3.55606724 |
| 60 | ribosome assembly (GO:0042255) | 3.54113600 |
| 61 | mitotic sister chromatid cohesion (GO:0007064) | 3.52967472 |
| 62 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.52197118 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 3.51614864 |
| 64 | regulation of fibrinolysis (GO:0051917) | 3.47919625 |
| 65 | short-chain fatty acid metabolic process (GO:0046459) | 3.46783440 |
| 66 | regulation of translational fidelity (GO:0006450) | 3.41916103 |
| 67 | fatty acid catabolic process (GO:0009062) | 3.41068436 |
| 68 | regulation of spindle organization (GO:0090224) | 3.40260171 |
| 69 | aromatic amino acid family metabolic process (GO:0009072) | 3.38837910 |
| 70 | cellular ketone body metabolic process (GO:0046950) | 3.38011608 |
| 71 | drug catabolic process (GO:0042737) | 3.36876221 |
| 72 | DNA duplex unwinding (GO:0032508) | 3.32474411 |
| 73 | ribonucleoprotein complex disassembly (GO:0032988) | 3.32195393 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 3.31746639 |
| 75 | alpha-amino acid catabolic process (GO:1901606) | 3.29915135 |
| 76 | acylglycerol homeostasis (GO:0055090) | 3.29835831 |
| 77 | triglyceride homeostasis (GO:0070328) | 3.29835831 |
| 78 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.29594902 |
| 79 | bile acid metabolic process (GO:0008206) | 3.28407543 |
| 80 | acetyl-CoA metabolic process (GO:0006084) | 3.28118413 |
| 81 | plasma lipoprotein particle clearance (GO:0034381) | 3.26884430 |
| 82 | regulation of sequestering of triglyceride (GO:0010889) | 3.25847157 |
| 83 | complement activation (GO:0006956) | 3.25764317 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.25629654 |
| 85 | complement activation, classical pathway (GO:0006958) | 3.25121873 |
| 86 | tyrosine metabolic process (GO:0006570) | 3.22416720 |
| 87 | DNA geometric change (GO:0032392) | 3.21731486 |
| 88 | fibrinolysis (GO:0042730) | 3.20946093 |
| 89 | benzene-containing compound metabolic process (GO:0042537) | 3.19797143 |
| 90 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.19333397 |
| 91 | DNA strand elongation (GO:0022616) | 3.18804916 |
| 92 | branched-chain amino acid metabolic process (GO:0009081) | 3.18606045 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.18085723 |
| 94 | regulation of cholesterol homeostasis (GO:2000188) | 3.17451432 |
| 95 | positive regulation of fatty acid oxidation (GO:0046321) | 3.16398956 |
| 96 | indolalkylamine metabolic process (GO:0006586) | 3.15994966 |
| 97 | DNA replication initiation (GO:0006270) | 3.15623180 |
| 98 | fatty acid transmembrane transport (GO:1902001) | 3.15139604 |
| 99 | reverse cholesterol transport (GO:0043691) | 3.14727577 |
| 100 | non-recombinational repair (GO:0000726) | 3.14705169 |
| 101 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.14705169 |
| 102 | regulation of histone H3-K27 methylation (GO:0061085) | 3.14669274 |
| 103 | cellular glucuronidation (GO:0052695) | 3.13059246 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.11309105 |
| 105 | mitotic metaphase plate congression (GO:0007080) | 3.11240966 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 3.10025900 |
| 107 | tricarboxylic acid metabolic process (GO:0072350) | 3.09647986 |
| 108 | vesicle coating (GO:0006901) | 3.09078546 |
| 109 | cellular modified amino acid catabolic process (GO:0042219) | 3.08264441 |
| 110 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.06299333 |
| 111 | exogenous drug catabolic process (GO:0042738) | 3.06224302 |
| 112 | tricarboxylic acid cycle (GO:0006099) | 3.03097466 |
| 113 | cellular biogenic amine catabolic process (GO:0042402) | 3.02371659 |
| 114 | amine catabolic process (GO:0009310) | 3.02371659 |
| 115 | epoxygenase P450 pathway (GO:0019373) | 3.00238308 |
| 116 | organic acid catabolic process (GO:0016054) | 3.00179405 |
| 117 | carboxylic acid catabolic process (GO:0046395) | 3.00179405 |
| 118 | protein localization to kinetochore (GO:0034501) | 2.99777264 |
| 119 | negative regulation of protein activation cascade (GO:2000258) | 2.99366336 |
| 120 | plasma lipoprotein particle remodeling (GO:0034369) | 2.98965761 |
| 121 | protein-lipid complex remodeling (GO:0034368) | 2.98965761 |
| 122 | macromolecular complex remodeling (GO:0034367) | 2.98965761 |
| 123 | protein localization to chromosome, centromeric region (GO:0071459) | 2.98955825 |
| 124 | drug transport (GO:0015893) | 2.98821217 |
| 125 | establishment of integrated proviral latency (GO:0075713) | 2.98790049 |
| 126 | aspartate family amino acid catabolic process (GO:0009068) | 2.98421286 |
| 127 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.98254391 |
| 128 | branched-chain amino acid catabolic process (GO:0009083) | 2.97906423 |
| 129 | DNA conformation change (GO:0071103) | 2.97477233 |
| 130 | phospholipid efflux (GO:0033700) | 2.97391428 |
| 131 | protein activation cascade (GO:0072376) | 2.96755137 |
| 132 | protein export from nucleus (GO:0006611) | 2.93950525 |
| 133 | tRNA aminoacylation for protein translation (GO:0006418) | 2.92046656 |
| 134 | negative regulation of chromosome segregation (GO:0051985) | 2.91521900 |
| 135 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.91405175 |
| 136 | low-density lipoprotein particle clearance (GO:0034383) | 2.90857137 |
| 137 | mitotic spindle checkpoint (GO:0071174) | 2.90446939 |
| 138 | mitotic spindle assembly checkpoint (GO:0007094) | 2.90166773 |
| 139 | regulation of chromosome segregation (GO:0051983) | 2.90004782 |
| 140 | negative regulation of cholesterol transport (GO:0032375) | 2.89951012 |
| 141 | negative regulation of sterol transport (GO:0032372) | 2.89951012 |
| 142 | glutamate metabolic process (GO:0006536) | 2.89917959 |
| 143 | response to mercury ion (GO:0046689) | 2.89653299 |
| 144 | ethanol metabolic process (GO:0006067) | 2.89428466 |
| 145 | biotin metabolic process (GO:0006768) | 2.88663317 |
| 146 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.88597281 |
| 147 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.88597281 |
| 148 | negative regulation of sister chromatid segregation (GO:0033046) | 2.88597281 |
| 149 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.88597281 |
| 150 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.88597281 |
| 151 | chromosome condensation (GO:0030261) | 2.87627967 |
| 152 | regulation of sister chromatid cohesion (GO:0007063) | 2.86841915 |
| 153 | spindle assembly checkpoint (GO:0071173) | 2.86775066 |
| 154 | glucuronate metabolic process (GO:0019585) | 2.86501958 |
| 155 | uronic acid metabolic process (GO:0006063) | 2.86501958 |
| 156 | nuclear envelope organization (GO:0006998) | 2.82626750 |
| 157 | metaphase plate congression (GO:0051310) | 2.82213006 |
| 158 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.82075349 |
| 159 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.82075349 |
| 160 | spindle checkpoint (GO:0031577) | 2.81833548 |
| 161 | amino acid activation (GO:0043038) | 2.79944185 |
| 162 | tRNA aminoacylation (GO:0043039) | 2.79944185 |
| 163 | regulation of centrosome cycle (GO:0046605) | 2.78612908 |
| 164 | positive regulation of cell cycle checkpoint (GO:1901978) | 2.75447867 |
| 165 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.71255264 |
| 166 | DNA replication checkpoint (GO:0000076) | 2.70583851 |
| 167 | regulation of sister chromatid segregation (GO:0033045) | 2.70548527 |
| 168 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.70548527 |
| 169 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.70548527 |
| 170 | definitive hemopoiesis (GO:0060216) | 2.69713006 |
| 171 | pre-miRNA processing (GO:0031054) | 2.69165173 |
| 172 | establishment of chromosome localization (GO:0051303) | 2.65472246 |
| 173 | mitotic recombination (GO:0006312) | 2.65386607 |
| 174 | mRNA transport (GO:0051028) | 2.64820331 |
| 175 | telomere maintenance via recombination (GO:0000722) | 2.63695274 |
| 176 | chromosome segregation (GO:0007059) | 2.62981764 |
| 177 | DNA packaging (GO:0006323) | 2.61802487 |
| 178 | regulation of centrosome duplication (GO:0010824) | 2.61721048 |
| 179 | mitotic G2/M transition checkpoint (GO:0044818) | 2.60698404 |
| 180 | purine nucleobase biosynthetic process (GO:0009113) | 2.57993512 |
| 181 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.56735628 |
| 182 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.54294840 |
| 183 | regulation of histone H3-K9 methylation (GO:0051570) | 2.51851544 |
| 184 | IMP biosynthetic process (GO:0006188) | 2.50929356 |
| 185 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.49243338 |
| 186 | histone H2B ubiquitination (GO:0033523) | 2.48678280 |
| 187 | diterpenoid biosynthetic process (GO:0016102) | 2.47415551 |
| 188 | kinetochore organization (GO:0051383) | 2.46476549 |
| 189 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.46244191 |
| 190 | IMP metabolic process (GO:0046040) | 2.44008747 |
| 191 | glutamine metabolic process (GO:0006541) | 2.43723634 |
| 192 | regulation of histone H3-K4 methylation (GO:0051569) | 2.41476346 |
| 193 | peptidyl-lysine dimethylation (GO:0018027) | 2.40287745 |
| 194 | histone H3-K9 demethylation (GO:0033169) | 2.39526009 |
| 195 | DNA ligation (GO:0006266) | 2.39519070 |
| 196 | regulation of DNA damage checkpoint (GO:2000001) | 2.39154307 |
| 197 | negative regulation of histone methylation (GO:0031061) | 2.38875098 |
| 198 | organelle disassembly (GO:1903008) | 2.38688293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.08067621 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.52468774 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.51318414 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.86176203 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.81844878 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.47582869 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.21141371 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.77553563 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.72446168 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.31288925 |
| 11 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.27071117 |
| 12 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 3.24175386 |
| 13 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 3.04553070 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03683038 |
| 15 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.96314985 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.77441667 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.76895136 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.75850333 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.75365551 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.60884152 |
| 21 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.50307344 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.49876760 |
| 23 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.47708960 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.41952948 |
| 25 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.41390150 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.40085098 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.35965021 |
| 28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.32848319 |
| 29 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.30267511 |
| 30 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.29758728 |
| 31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.26205075 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.20487959 |
| 33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.16829618 |
| 34 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.15654433 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.13064298 |
| 36 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.09226400 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.08033460 |
| 38 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.05094658 |
| 39 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.97591729 |
| 40 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.97309423 |
| 41 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.95967808 |
| 42 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.95903579 |
| 43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.95715798 |
| 44 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.92864221 |
| 45 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.91941790 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.77237525 |
| 47 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.76047890 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75131653 |
| 49 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74696222 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74255503 |
| 51 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.74211775 |
| 52 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71939110 |
| 53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.68744704 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65746828 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64034245 |
| 56 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.62027984 |
| 57 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60154312 |
| 58 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.59722861 |
| 59 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.57767982 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56567921 |
| 61 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.54879032 |
| 62 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.54544039 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52768753 |
| 64 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.50791312 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48667506 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48362797 |
| 67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48360372 |
| 68 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.47212571 |
| 69 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.45941645 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.42154913 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41727379 |
| 72 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.41357458 |
| 73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37953236 |
| 74 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37306929 |
| 75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37064932 |
| 76 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.37029877 |
| 77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.35474692 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.34037871 |
| 79 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.33774128 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32048370 |
| 81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.30083651 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28904062 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28423802 |
| 84 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26791509 |
| 85 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.26210560 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26095716 |
| 87 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.26089140 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.23444711 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23216201 |
| 90 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.21204294 |
| 91 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20965245 |
| 92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20815927 |
| 93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19649156 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.18687585 |
| 95 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.18515775 |
| 96 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17601295 |
| 97 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.16301763 |
| 98 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15237913 |
| 99 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.14575600 |
| 100 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13996367 |
| 101 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.12431618 |
| 102 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.11928067 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11873431 |
| 104 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.11623436 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10617889 |
| 106 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.10187455 |
| 107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.09209698 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08565085 |
| 109 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.08541944 |
| 110 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.06922384 |
| 111 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06530626 |
| 112 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.06489222 |
| 113 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.04428005 |
| 114 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.03571813 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.03383244 |
| 116 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02862179 |
| 117 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02772719 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.02157252 |
| 119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.02157252 |
| 120 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01842589 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01698103 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01253022 |
| 123 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.00744297 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98637337 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.97173655 |
| 126 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.95432819 |
| 127 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.94671252 |
| 128 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93933762 |
| 129 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.91835942 |
| 130 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91592362 |
| 131 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.91293365 |
| 132 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91282232 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89842249 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89842249 |
| 135 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.89327222 |
| 136 | * MAF_26560356_Chip-Seq_TH1_Human | 0.88759755 |
| 137 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.88688178 |
| 138 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.88564883 |
| 139 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88075370 |
| 140 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.87989644 |
| 141 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.87723641 |
| 142 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87213019 |
| 143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87156279 |
| 144 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.86563512 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.86526587 |
| 146 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86287926 |
| 147 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85924177 |
| 148 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85441643 |
| 149 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.85274070 |
| 150 | FUS_26573619_Chip-Seq_HEK293_Human | 0.84431235 |
| 151 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84210958 |
| 152 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.84191042 |
| 153 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84159897 |
| 154 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.83838591 |
| 155 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83604085 |
| 156 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83556386 |
| 157 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81730632 |
| 158 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81178771 |
| 159 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81090195 |
| 160 | * MYB_26560356_Chip-Seq_TH2_Human | 0.80598469 |
| 161 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79906956 |
| 162 | * MYB_26560356_Chip-Seq_TH1_Human | 0.79083595 |
| 163 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78807018 |
| 164 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78129532 |
| 165 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.77257503 |
| 166 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75988542 |
| 167 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75491491 |
| 168 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75408027 |
| 169 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74673232 |
| 170 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.73887234 |
| 171 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.73757679 |
| 172 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73093161 |
| 173 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72799594 |
| 174 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.71140765 |
| 175 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.70805454 |
| 176 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70252140 |
| 177 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70228970 |
| 178 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.69277405 |
| 179 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.69041307 |
| 180 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68092043 |
| 181 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68038736 |
| 182 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.66958875 |
| 183 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.66631655 |
| 184 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.66311470 |
| 185 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.65900110 |
| 186 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.65790120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.56572525 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.47509305 |
| 3 | MP0005365_abnormal_bile_salt | 3.96174793 |
| 4 | MP0008057_abnormal_DNA_replication | 3.90442848 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.80663863 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.44806421 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.11375361 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.93644464 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.85640332 |
| 10 | MP0003252_abnormal_bile_duct | 2.80097535 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 2.68260325 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.62307625 |
| 13 | MP0003077_abnormal_cell_cycle | 2.51284784 |
| 14 | MP0005332_abnormal_amino_acid | 2.50187738 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.46598019 |
| 16 | MP0005408_hypopigmentation | 2.43758654 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.35102513 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.32121409 |
| 19 | MP0003941_abnormal_skin_development | 2.30993925 |
| 20 | MP0009840_abnormal_foam_cell | 2.26109908 |
| 21 | MP0008932_abnormal_embryonic_tissue | 2.16023714 |
| 22 | MP0008058_abnormal_DNA_repair | 2.12250450 |
| 23 | MP0003221_abnormal_cardiomyocyte_apopto | 2.07102332 |
| 24 | MP0005670_abnormal_white_adipose | 2.06562258 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 2.03192632 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.99014887 |
| 27 | MP0005171_absent_coat_pigmentation | 1.97991430 |
| 28 | MP0003724_increased_susceptibility_to | 1.97458778 |
| 29 | MP0001730_embryonic_growth_arrest | 1.95301263 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.94012648 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.93072209 |
| 32 | MP0003984_embryonic_growth_retardation | 1.89509065 |
| 33 | MP0003195_calcinosis | 1.87784945 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.86057475 |
| 35 | MP0004272_abnormal_basement_membrane | 1.85274809 |
| 36 | MP0002088_abnormal_embryonic_growth/wei | 1.84888595 |
| 37 | MP0001672_abnormal_embryogenesis/_devel | 1.84840255 |
| 38 | MP0005380_embryogenesis_phenotype | 1.84840255 |
| 39 | MP0005083_abnormal_biliary_tract | 1.84781627 |
| 40 | MP0000609_abnormal_liver_physiology | 1.83817781 |
| 41 | MP0001697_abnormal_embryo_size | 1.76811963 |
| 42 | MP0000350_abnormal_cell_proliferation | 1.70924863 |
| 43 | MP0009643_abnormal_urine_homeostasis | 1.70902615 |
| 44 | MP0010368_abnormal_lymphatic_system | 1.70733197 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.70426457 |
| 46 | MP0004233_abnormal_muscle_weight | 1.69148994 |
| 47 | MP0000372_irregular_coat_pigmentation | 1.66330371 |
| 48 | MP0002118_abnormal_lipid_homeostasis | 1.61736020 |
| 49 | MP0004130_abnormal_muscle_cell | 1.60539337 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.58948190 |
| 51 | MP0008438_abnormal_cutaneous_collagen | 1.57671798 |
| 52 | MP0004084_abnormal_cardiac_muscle | 1.56705178 |
| 53 | MP0002086_abnormal_extraembryonic_tissu | 1.55965265 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.54840911 |
| 55 | MP0010307_abnormal_tumor_latency | 1.54012092 |
| 56 | MP0004264_abnormal_extraembryonic_tissu | 1.52006685 |
| 57 | MP0002084_abnormal_developmental_patter | 1.50050660 |
| 58 | MP0003436_decreased_susceptibility_to | 1.49352586 |
| 59 | MP0009764_decreased_sensitivity_to | 1.49261376 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.49093914 |
| 61 | MP0002269_muscular_atrophy | 1.48764813 |
| 62 | MP0003567_abnormal_fetal_cardiomyocyte | 1.46346549 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46175733 |
| 64 | MP0002080_prenatal_lethality | 1.45492124 |
| 65 | MP0001958_emphysema | 1.45333940 |
| 66 | MP0001666_abnormal_nutrient_absorption | 1.41976850 |
| 67 | MP0002009_preneoplasia | 1.39757007 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.37147541 |
| 69 | MP0003890_abnormal_embryonic-extraembry | 1.35336790 |
| 70 | MP0005666_abnormal_adipose_tissue | 1.35175645 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.35071744 |
| 72 | MP0001915_intracranial_hemorrhage | 1.33088051 |
| 73 | MP0003385_abnormal_body_wall | 1.30145185 |
| 74 | MP0008995_early_reproductive_senescence | 1.29692134 |
| 75 | MP0002136_abnormal_kidney_physiology | 1.26545371 |
| 76 | MP0005248_abnormal_Harderian_gland | 1.25016790 |
| 77 | MP0003786_premature_aging | 1.22900095 |
| 78 | MP0009672_abnormal_birth_weight | 1.22242830 |
| 79 | MP0010630_abnormal_cardiac_muscle | 1.21452769 |
| 80 | MP0002085_abnormal_embryonic_tissue | 1.20759763 |
| 81 | MP0001879_abnormal_lymphatic_vessel | 1.20027394 |
| 82 | MP0008469_abnormal_protein_level | 1.19799398 |
| 83 | MP0003718_maternal_effect | 1.19789231 |
| 84 | MP0005076_abnormal_cell_differentiation | 1.19537868 |
| 85 | MP0004197_abnormal_fetal_growth/weight/ | 1.16941720 |
| 86 | MP0001661_extended_life_span | 1.16847339 |
| 87 | MP0005275_abnormal_skin_tensile | 1.16628820 |
| 88 | MP0002697_abnormal_eye_size | 1.14936113 |
| 89 | MP0001756_abnormal_urination | 1.14884268 |
| 90 | MP0005464_abnormal_platelet_physiology | 1.12909638 |
| 91 | MP0004036_abnormal_muscle_relaxation | 1.12437756 |
| 92 | MP0009785_altered_susceptibility_to | 1.11604676 |
| 93 | MP0005387_immune_system_phenotype | 1.11008328 |
| 94 | MP0001790_abnormal_immune_system | 1.11008328 |
| 95 | MP0003943_abnormal_hepatobiliary_system | 1.09950664 |
| 96 | MP0002971_abnormal_brown_adipose | 1.07131526 |
| 97 | MP0003186_abnormal_redox_activity | 1.06449019 |
| 98 | MP0009763_increased_sensitivity_to | 1.06014027 |
| 99 | MP0001800_abnormal_humoral_immune | 1.05472913 |
| 100 | MP0000313_abnormal_cell_death | 1.03629721 |
| 101 | MP0009703_decreased_birth_body | 1.03277078 |
| 102 | MP0002419_abnormal_innate_immunity | 1.03175599 |
| 103 | MP0000685_abnormal_immune_system | 1.03037511 |
| 104 | MP0000598_abnormal_liver_morphology | 1.01940041 |
| 105 | MP0005451_abnormal_body_composition | 1.01438470 |
| 106 | MP0006138_congestive_heart_failure | 1.00044998 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.99462393 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.99356327 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.99178194 |
| 110 | MP0002168_other_aberrant_phenotype | 0.99057933 |
| 111 | MP0001764_abnormal_homeostasis | 0.99033118 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.98782520 |
| 113 | MP0000371_diluted_coat_color | 0.98762626 |
| 114 | MP0000358_abnormal_cell_content/ | 0.98633772 |
| 115 | MP0002254_reproductive_system_inflammat | 0.98225127 |
| 116 | MP0003279_aneurysm | 0.98015735 |
| 117 | MP0004087_abnormal_muscle_fiber | 0.96858949 |
| 118 | MP0001853_heart_inflammation | 0.96795254 |
| 119 | MP0000747_muscle_weakness | 0.96586860 |
| 120 | MP0004147_increased_porphyrin_level | 0.96128676 |
| 121 | MP0003937_abnormal_limbs/digits/tail_de | 0.94898773 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.93801914 |
| 123 | MP0003656_abnormal_erythrocyte_physiolo | 0.92846649 |
| 124 | MP0006082_CNS_inflammation | 0.92828414 |
| 125 | MP0004185_abnormal_adipocyte_glucose | 0.92450720 |
| 126 | MP0000343_altered_response_to | 0.92425207 |
| 127 | MP0005621_abnormal_cell_physiology | 0.92041333 |
| 128 | MP0004947_skin_inflammation | 0.91642517 |
| 129 | MP0005025_abnormal_response_to | 0.90746653 |
| 130 | MP0005384_cellular_phenotype | 0.90716806 |
| 131 | MP0008260_abnormal_autophagy | 0.89293568 |
| 132 | MP0003868_abnormal_feces_composition | 0.88922142 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.86289844 |
| 134 | MP0002092_abnormal_eye_morphology | 0.86240402 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.86143776 |
| 136 | MP0001293_anophthalmia | 0.85985636 |
| 137 | MP0002452_abnormal_antigen_presenting | 0.85289745 |
| 138 | MP0003566_abnormal_cell_adhesion | 0.85281344 |
| 139 | MP0008775_abnormal_heart_ventricle | 0.85080010 |
| 140 | MP0002938_white_spotting | 0.84844126 |
| 141 | MP0005023_abnormal_wound_healing | 0.84785568 |
| 142 | MP0005334_abnormal_fat_pad | 0.83290172 |
| 143 | MP0005330_cardiomyopathy | 0.82707677 |
| 144 | MP0003935_abnormal_craniofacial_develop | 0.81786224 |
| 145 | MP0009697_abnormal_copulation | 0.81745043 |
| 146 | MP0000249_abnormal_blood_vessel | 0.81402427 |
| 147 | MP0009115_abnormal_fat_cell | 0.81265581 |
| 148 | MP0005000_abnormal_immune_tolerance | 0.81106633 |
| 149 | MP0009642_abnormal_blood_homeostasis | 0.80920653 |
| 150 | MP0003303_peritoneal_inflammation | 0.79953631 |
| 151 | MP0005375_adipose_tissue_phenotype | 0.79874261 |
| 152 | MP0004808_abnormal_hematopoietic_stem | 0.78737002 |
| 153 | MP0002723_abnormal_immune_serum | 0.77872824 |
| 154 | MP0005647_abnormal_sex_gland | 0.77639174 |
| 155 | MP0000604_amyloidosis | 0.77585380 |
| 156 | MP0000266_abnormal_heart_morphology | 0.77530130 |
| 157 | MP0002933_joint_inflammation | 0.76569289 |
| 158 | MP0001727_abnormal_embryo_implantation | 0.76166259 |
| 159 | MP0001286_abnormal_eye_development | 0.75937430 |
| 160 | MP0000751_myopathy | 0.75769256 |
| 161 | MP0003115_abnormal_respiratory_system | 0.75523378 |
| 162 | MP0005671_abnormal_response_to | 0.75069709 |
| 163 | MP0005167_abnormal_blood-brain_barrier | 0.74979778 |
| 164 | MP0002060_abnormal_skin_morphology | 0.73389691 |
| 165 | MP0002928_abnormal_bile_duct | 0.72989965 |
| 166 | MP0005166_decreased_susceptibility_to | 0.72031598 |
| 167 | MP0006035_abnormal_mitochondrial_morpho | 0.71611532 |
| 168 | MP0000537_abnormal_urethra_morphology | 0.71315491 |
| 169 | MP0001765_abnormal_ion_homeostasis | 0.70926831 |
| 170 | MP0003011_delayed_dark_adaptation | 0.70837450 |
| 171 | MP0010234_abnormal_vibrissa_follicle | 0.70308823 |
| 172 | MP0002135_abnormal_kidney_morphology | 0.69531223 |
| 173 | MP0002132_abnormal_respiratory_system | 0.67980705 |
| 174 | MP0010155_abnormal_intestine_physiology | 0.66313597 |
| 175 | MP0010678_abnormal_skin_adnexa | 0.65480314 |
| 176 | MP0000428_abnormal_craniofacial_morphol | 0.65097580 |
| 177 | MP0002075_abnormal_coat/hair_pigmentati | 0.64746870 |
| 178 | MP0002405_respiratory_system_inflammati | 0.64301162 |
| 179 | MP0002420_abnormal_adaptive_immunity | 0.64181217 |
| 180 | MP0002128_abnormal_blood_circulation | 0.64075887 |
| 181 | MP0002078_abnormal_glucose_homeostasis | 0.63543299 |
| 182 | MP0001819_abnormal_immune_cell | 0.63474536 |
| 183 | MP0002925_abnormal_cardiovascular_devel | 0.62998760 |
| 184 | MP0002019_abnormal_tumor_incidence | 0.62905722 |
| 185 | MP0005187_abnormal_penis_morphology | 0.62152813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.11445681 |
| 2 | Xanthomatosis (HP:0000991) | 4.57615565 |
| 3 | Complement deficiency (HP:0004431) | 4.55719217 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.44436676 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.14440199 |
| 6 | Papillary thyroid carcinoma (HP:0002895) | 4.13948565 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.91035134 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90082732 |
| 9 | Hyperglycinuria (HP:0003108) | 3.85102801 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.81452707 |
| 11 | Joint hemorrhage (HP:0005261) | 3.72970254 |
| 12 | Cortical dysplasia (HP:0002539) | 3.72941211 |
| 13 | Prolonged partial thromboplastin time (HP:0003645) | 3.62274420 |
| 14 | Hyperammonemia (HP:0001987) | 3.60863192 |
| 15 | Ketosis (HP:0001946) | 3.56355496 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 3.48217610 |
| 17 | Chromsome breakage (HP:0040012) | 3.45648618 |
| 18 | Systemic lupus erythematosus (HP:0002725) | 3.43036485 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.41535853 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.41535853 |
| 21 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.40641795 |
| 22 | Myocardial infarction (HP:0001658) | 3.40628446 |
| 23 | Abnormality of complement system (HP:0005339) | 3.37075427 |
| 24 | Abnormality of glycolysis (HP:0004366) | 3.30860315 |
| 25 | Abnormality of the common coagulation pathway (HP:0010990) | 3.26389506 |
| 26 | Increased serum pyruvate (HP:0003542) | 3.21766968 |
| 27 | Cholecystitis (HP:0001082) | 3.15709567 |
| 28 | Abnormal gallbladder physiology (HP:0012438) | 3.15709567 |
| 29 | Ketoacidosis (HP:0001993) | 3.10445517 |
| 30 | Gout (HP:0001997) | 3.09389621 |
| 31 | Abnormality of purine metabolism (HP:0004352) | 3.08278685 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.03987476 |
| 33 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.03794801 |
| 34 | Hyperglycinemia (HP:0002154) | 3.02159150 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.00965829 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.97604205 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.93875057 |
| 38 | Epidermoid cyst (HP:0200040) | 2.93726273 |
| 39 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.91573078 |
| 40 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.88391509 |
| 41 | Mitral stenosis (HP:0001718) | 2.86472499 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.85243730 |
| 43 | Thyroid carcinoma (HP:0002890) | 2.83780271 |
| 44 | Hypoglycemic coma (HP:0001325) | 2.83210369 |
| 45 | Termporal pattern (HP:0011008) | 2.82881475 |
| 46 | Insidious onset (HP:0003587) | 2.82881475 |
| 47 | Vascular calcification (HP:0004934) | 2.79908238 |
| 48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.74564760 |
| 49 | Glomerulonephritis (HP:0000099) | 2.73168917 |
| 50 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.71245280 |
| 51 | Cardiovascular calcification (HP:0011915) | 2.70500182 |
| 52 | Embryonal renal neoplasm (HP:0011794) | 2.68076670 |
| 53 | Acute myeloid leukemia (HP:0004808) | 2.65256608 |
| 54 | Overlapping toe (HP:0001845) | 2.61397324 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.59292817 |
| 56 | Hydroxyprolinuria (HP:0003080) | 2.59292817 |
| 57 | Asymmetry of the thorax (HP:0001555) | 2.58465274 |
| 58 | Nephritis (HP:0000123) | 2.56541993 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.54233029 |
| 60 | Increased nuchal translucency (HP:0010880) | 2.50226846 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.47585784 |
| 62 | Proximal tubulopathy (HP:0000114) | 2.44923977 |
| 63 | Fat malabsorption (HP:0002630) | 2.41150889 |
| 64 | Metabolic acidosis (HP:0001942) | 2.40774628 |
| 65 | Hyperuricemia (HP:0002149) | 2.40011085 |
| 66 | Increased purine levels (HP:0004368) | 2.40011085 |
| 67 | Ankyloglossia (HP:0010296) | 2.38065661 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.37910172 |
| 69 | Generalized aminoaciduria (HP:0002909) | 2.37680382 |
| 70 | Skin nodule (HP:0200036) | 2.37118243 |
| 71 | Esophageal varix (HP:0002040) | 2.36626852 |
| 72 | Dicarboxylic aciduria (HP:0003215) | 2.32261017 |
| 73 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.32261017 |
| 74 | Deep philtrum (HP:0002002) | 2.31109962 |
| 75 | Abnormality of methionine metabolism (HP:0010901) | 2.26895771 |
| 76 | Reticulocytosis (HP:0001923) | 2.26890104 |
| 77 | Orthostatic hypotension (HP:0001278) | 2.26638506 |
| 78 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25216659 |
| 79 | Abnormality of serum amino acid levels (HP:0003112) | 2.25058840 |
| 80 | Polycythemia (HP:0001901) | 2.23506024 |
| 81 | Abnormality of chromosome stability (HP:0003220) | 2.22804021 |
| 82 | Sensorimotor neuropathy (HP:0007141) | 2.19620276 |
| 83 | Thrombophlebitis (HP:0004418) | 2.18089602 |
| 84 | Medulloblastoma (HP:0002885) | 2.16155713 |
| 85 | Microglossia (HP:0000171) | 2.16150543 |
| 86 | Hypokalemic alkalosis (HP:0001949) | 2.14222969 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.13916456 |
| 88 | Alkalosis (HP:0001948) | 2.13200144 |
| 89 | Microvesicular hepatic steatosis (HP:0001414) | 2.13129150 |
| 90 | Hyperactive renin-angiotensin system (HP:0000841) | 2.11033662 |
| 91 | Alacrima (HP:0000522) | 2.10226789 |
| 92 | Gingival bleeding (HP:0000225) | 2.08864714 |
| 93 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.07136912 |
| 94 | Pheochromocytoma (HP:0002666) | 2.05389920 |
| 95 | Neoplasm of the small intestine (HP:0100833) | 2.05005500 |
| 96 | Delayed CNS myelination (HP:0002188) | 2.04497655 |
| 97 | Breech presentation (HP:0001623) | 2.03868609 |
| 98 | Hypertriglyceridemia (HP:0002155) | 2.03286662 |
| 99 | Abnormal lung lobation (HP:0002101) | 2.03079999 |
| 100 | Pancreatitis (HP:0001733) | 2.03007097 |
| 101 | Pulmonary embolism (HP:0002204) | 2.02846809 |
| 102 | Ovarian neoplasm (HP:0100615) | 1.99469784 |
| 103 | Vacuolated lymphocytes (HP:0001922) | 1.98303304 |
| 104 | Sandal gap (HP:0001852) | 1.98272778 |
| 105 | Eczematoid dermatitis (HP:0000976) | 1.98046880 |
| 106 | Right ventricular cardiomyopathy (HP:0011663) | 1.97096132 |
| 107 | Myoglobinuria (HP:0002913) | 1.95629312 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 1.95129842 |
| 109 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.94883879 |
| 110 | Neonatal onset (HP:0003623) | 1.94789682 |
| 111 | Exercise-induced muscle cramps (HP:0003710) | 1.93143692 |
| 112 | Acanthocytosis (HP:0001927) | 1.92796667 |
| 113 | Hyperbilirubinemia (HP:0002904) | 1.92678425 |
| 114 | Gonadotropin excess (HP:0000837) | 1.88675239 |
| 115 | Aortic aneurysm (HP:0004942) | 1.88430094 |
| 116 | Hemorrhage of the eye (HP:0011885) | 1.87779808 |
| 117 | Decreased lacrimation (HP:0000633) | 1.87556625 |
| 118 | Lymphangioma (HP:0100764) | 1.86525287 |
| 119 | Spastic diplegia (HP:0001264) | 1.86149485 |
| 120 | Rhabdomyosarcoma (HP:0002859) | 1.82904917 |
| 121 | Hypoparathyroidism (HP:0000829) | 1.82736761 |
| 122 | Steatorrhea (HP:0002570) | 1.82493548 |
| 123 | Autoimmune thrombocytopenia (HP:0001973) | 1.82466119 |
| 124 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.81510756 |
| 125 | Abnormality of chloride homeostasis (HP:0011422) | 1.81203372 |
| 126 | Cholelithiasis (HP:0001081) | 1.80791142 |
| 127 | Multiple enchondromatosis (HP:0005701) | 1.80521323 |
| 128 | Amyloidosis (HP:0011034) | 1.79585373 |
| 129 | Abnormality of the nasal mucosa (HP:0000433) | 1.79340191 |
| 130 | Hypopigmentation of the fundus (HP:0007894) | 1.78298293 |
| 131 | Lower limb hyperreflexia (HP:0002395) | 1.78230295 |
| 132 | Hematochezia (HP:0002573) | 1.78134012 |
| 133 | Long clavicles (HP:0000890) | 1.78033391 |
| 134 | Proximal placement of thumb (HP:0009623) | 1.76933224 |
| 135 | Relative macrocephaly (HP:0004482) | 1.76112344 |
| 136 | Myelodysplasia (HP:0002863) | 1.75530912 |
| 137 | Rimmed vacuoles (HP:0003805) | 1.75390402 |
| 138 | Renal cortical cysts (HP:0000803) | 1.75269857 |
| 139 | Broad palm (HP:0001169) | 1.75185940 |
| 140 | Axonal loss (HP:0003447) | 1.74881938 |
| 141 | Colitis (HP:0002583) | 1.74762469 |
| 142 | Upper limb muscle weakness (HP:0003484) | 1.74720014 |
| 143 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74663048 |
| 144 | Bowel incontinence (HP:0002607) | 1.74626772 |
| 145 | Deviation of the thumb (HP:0009603) | 1.74565898 |
| 146 | Lethargy (HP:0001254) | 1.74336461 |
| 147 | Abnormal gallbladder morphology (HP:0012437) | 1.73440144 |
| 148 | Vomiting (HP:0002013) | 1.72092723 |
| 149 | Leiomyosarcoma (HP:0100243) | 1.71921229 |
| 150 | Uterine leiomyosarcoma (HP:0002891) | 1.71921229 |
| 151 | Cutaneous melanoma (HP:0012056) | 1.71578110 |
| 152 | Rhabdomyolysis (HP:0003201) | 1.71140195 |
| 153 | Abnormality of oral frenula (HP:0000190) | 1.70409321 |
| 154 | Hepatoblastoma (HP:0002884) | 1.70209793 |
| 155 | Spontaneous abortion (HP:0005268) | 1.70119436 |
| 156 | Menorrhagia (HP:0000132) | 1.70103395 |
| 157 | Volvulus (HP:0002580) | 1.68139122 |
| 158 | Arterial thrombosis (HP:0004420) | 1.67819626 |
| 159 | Chondrocalcinosis (HP:0000934) | 1.65993963 |
| 160 | Aortic dissection (HP:0002647) | 1.65660585 |
| 161 | Birth length less than 3rd percentile (HP:0003561) | 1.65423142 |
| 162 | Abnormal foot bone ossification (HP:0010675) | 1.65113319 |
| 163 | Long toe (HP:0010511) | 1.64975703 |
| 164 | Abnormality of the acetabulum (HP:0003170) | 1.64947664 |
| 165 | Secondary amenorrhea (HP:0000869) | 1.64798235 |
| 166 | Arterial tortuosity (HP:0005116) | 1.64368903 |
| 167 | Obsessive-compulsive behavior (HP:0000722) | 1.64229023 |
| 168 | Flat acetabular roof (HP:0003180) | 1.64189776 |
| 169 | Abnormal large intestine physiology (HP:0012700) | 1.63628282 |
| 170 | Facial cleft (HP:0002006) | 1.62014443 |
| 171 | Gonadal dysgenesis (HP:0000133) | 1.61602493 |
| 172 | Neoplasm of the thyroid gland (HP:0100031) | 1.60671029 |
| 173 | Palpitations (HP:0001962) | 1.59677746 |
| 174 | Truncus arteriosus (HP:0001660) | 1.59498218 |
| 175 | Cafe-au-lait spot (HP:0000957) | 1.59027516 |
| 176 | Entropion (HP:0000621) | 1.58101531 |
| 177 | Freckling (HP:0001480) | 1.57571387 |
| 178 | Abnormal auditory evoked potentials (HP:0006958) | 1.57400203 |
| 179 | Abnormality of reticulocytes (HP:0004312) | 1.56595064 |
| 180 | Impaired pain sensation (HP:0007328) | 1.55956650 |
| 181 | Abnormality of pain sensation (HP:0010832) | 1.55956650 |
| 182 | Subaortic stenosis (HP:0001682) | 1.55194570 |
| 183 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.55194570 |
| 184 | Seborrheic dermatitis (HP:0001051) | 1.55100839 |
| 185 | Rhizomelia (HP:0008905) | 1.54529624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTK | 3.38447917 |
| 2 | ERN1 | 3.33428137 |
| 3 | TGFBR2 | 3.21236647 |
| 4 | TRIB3 | 3.04474986 |
| 5 | FGFR4 | 3.03024277 |
| 6 | BCKDK | 2.96025183 |
| 7 | EIF2AK3 | 2.93809775 |
| 8 | EIF2AK1 | 2.92872816 |
| 9 | SRPK1 | 2.90471729 |
| 10 | SCYL2 | 2.65235089 |
| 11 | PLK4 | 2.65023255 |
| 12 | PBK | 2.52338072 |
| 13 | NEK1 | 2.42023838 |
| 14 | BCR | 2.16647149 |
| 15 | BRD4 | 2.13737072 |
| 16 | CDC7 | 2.10147112 |
| 17 | MAP4K1 | 2.09444469 |
| 18 | CDK12 | 2.08436294 |
| 19 | SIK1 | 2.05177483 |
| 20 | TIE1 | 2.04221239 |
| 21 | PKN2 | 2.00674862 |
| 22 | CLK1 | 1.93989402 |
| 23 | TTN | 1.90898575 |
| 24 | BRSK2 | 1.88617683 |
| 25 | RIPK1 | 1.86628257 |
| 26 | TYK2 | 1.80008896 |
| 27 | JAK1 | 1.73820671 |
| 28 | KSR2 | 1.72177092 |
| 29 | TAOK3 | 1.71547237 |
| 30 | TBK1 | 1.68253923 |
| 31 | EPHB1 | 1.67835470 |
| 32 | NEK9 | 1.67492606 |
| 33 | BMPR2 | 1.58726570 |
| 34 | BLK | 1.58337823 |
| 35 | KDR | 1.57748099 |
| 36 | BUB1 | 1.52625087 |
| 37 | EPHA3 | 1.51423965 |
| 38 | MAP3K2 | 1.46069246 |
| 39 | RPS6KB2 | 1.44336836 |
| 40 | MAP2K3 | 1.40985825 |
| 41 | TSSK6 | 1.40650533 |
| 42 | PTK6 | 1.39293882 |
| 43 | MAP3K14 | 1.38342531 |
| 44 | WEE1 | 1.35182214 |
| 45 | JAK3 | 1.33673832 |
| 46 | FGFR3 | 1.33626383 |
| 47 | ICK | 1.32359875 |
| 48 | RAF1 | 1.30524255 |
| 49 | AKT3 | 1.30491623 |
| 50 | FLT3 | 1.30092853 |
| 51 | CSK | 1.29139535 |
| 52 | CAMK1D | 1.28318352 |
| 53 | PIK3CG | 1.24121329 |
| 54 | MKNK1 | 1.23689223 |
| 55 | IKBKE | 1.22594923 |
| 56 | ZAP70 | 1.22413959 |
| 57 | WNK4 | 1.20982154 |
| 58 | MST1R | 1.20953820 |
| 59 | KIT | 1.20798082 |
| 60 | MAP3K4 | 1.18502176 |
| 61 | STK10 | 1.15605187 |
| 62 | LATS1 | 1.14454938 |
| 63 | PRKAA2 | 1.14044583 |
| 64 | IRAK3 | 1.13403537 |
| 65 | KSR1 | 1.13173023 |
| 66 | MAP3K3 | 1.12218624 |
| 67 | MST4 | 1.10481972 |
| 68 | ITK | 1.09436576 |
| 69 | MET | 1.08989599 |
| 70 | LRRK2 | 1.08915706 |
| 71 | JAK2 | 1.06072129 |
| 72 | OBSCN | 1.03760545 |
| 73 | LATS2 | 1.03165177 |
| 74 | PLK3 | 1.03029808 |
| 75 | ERBB3 | 1.03007723 |
| 76 | ATR | 1.01994081 |
| 77 | MAP3K13 | 1.01669668 |
| 78 | CHEK1 | 1.00607241 |
| 79 | INSRR | 1.00070575 |
| 80 | TXK | 0.98007347 |
| 81 | WNK3 | 0.97006124 |
| 82 | TEC | 0.96494795 |
| 83 | FGFR1 | 0.95857765 |
| 84 | TRIM28 | 0.95548310 |
| 85 | MAP3K7 | 0.95374768 |
| 86 | NLK | 0.95356172 |
| 87 | ATM | 0.94882489 |
| 88 | MAPK11 | 0.93490238 |
| 89 | ERBB4 | 0.92625932 |
| 90 | PLK1 | 0.91321810 |
| 91 | BTK | 0.90632985 |
| 92 | MAPKAPK3 | 0.89384465 |
| 93 | PAK4 | 0.89098904 |
| 94 | PDK4 | 0.88914030 |
| 95 | PDK3 | 0.88914030 |
| 96 | CCNB1 | 0.88450700 |
| 97 | EEF2K | 0.85248675 |
| 98 | RPS6KA4 | 0.85134778 |
| 99 | CSF1R | 0.83974449 |
| 100 | NEK2 | 0.83930220 |
| 101 | YES1 | 0.83661462 |
| 102 | CDK7 | 0.82751224 |
| 103 | IRAK1 | 0.79806463 |
| 104 | FRK | 0.79323943 |
| 105 | AURKB | 0.79181002 |
| 106 | TRPM7 | 0.78585528 |
| 107 | CHEK2 | 0.77652777 |
| 108 | PDK2 | 0.77495766 |
| 109 | TGFBR1 | 0.76781380 |
| 110 | MYLK | 0.76299019 |
| 111 | CAMK1G | 0.75730544 |
| 112 | GRK6 | 0.74574940 |
| 113 | IRAK4 | 0.74497238 |
| 114 | MAPK12 | 0.74328904 |
| 115 | PRKCH | 0.73893138 |
| 116 | STK24 | 0.72537225 |
| 117 | HCK | 0.71905446 |
| 118 | MAP3K12 | 0.71829815 |
| 119 | PIK3CA | 0.71790778 |
| 120 | TNIK | 0.71119469 |
| 121 | SGK3 | 0.70022891 |
| 122 | CDK4 | 0.69394726 |
| 123 | MAP3K10 | 0.69278954 |
| 124 | NEK6 | 0.68815592 |
| 125 | CDK9 | 0.68028935 |
| 126 | PDGFRA | 0.67760101 |
| 127 | PRKAA1 | 0.66878570 |
| 128 | CDK1 | 0.66497615 |
| 129 | LMTK2 | 0.65565419 |
| 130 | DMPK | 0.65397319 |
| 131 | MTOR | 0.65156597 |
| 132 | DYRK1B | 0.64968492 |
| 133 | CDK6 | 0.64740898 |
| 134 | CDK2 | 0.63843891 |
| 135 | MAP3K6 | 0.61978504 |
| 136 | IKBKB | 0.59820084 |
| 137 | MAPK4 | 0.59198556 |
| 138 | EIF2AK2 | 0.57009867 |
| 139 | ALK | 0.56575342 |
| 140 | AKT2 | 0.56547698 |
| 141 | PAK2 | 0.55689801 |
| 142 | IGF1R | 0.53926248 |
| 143 | STK4 | 0.53786406 |
| 144 | CHUK | 0.52820557 |
| 145 | GRK1 | 0.52352102 |
| 146 | MAP3K8 | 0.52189963 |
| 147 | PTK2 | 0.51665658 |
| 148 | EPHB2 | 0.50916125 |
| 149 | SGK2 | 0.49884964 |
| 150 | PINK1 | 0.49262039 |
| 151 | FER | 0.49254745 |
| 152 | IRAK2 | 0.49178958 |
| 153 | RET | 0.48625186 |
| 154 | CSNK1E | 0.48091875 |
| 155 | ABL1 | 0.47825509 |
| 156 | CSNK1A1L | 0.47582201 |
| 157 | SYK | 0.47421555 |
| 158 | PRKCQ | 0.46041732 |
| 159 | FGFR2 | 0.45676699 |
| 160 | MAP2K4 | 0.45124992 |
| 161 | STK3 | 0.44681625 |
| 162 | GSK3A | 0.44311247 |
| 163 | NME1 | 0.43996374 |
| 164 | LCK | 0.43214235 |
| 165 | MAP3K11 | 0.43009257 |
| 166 | STK38L | 0.42666186 |
| 167 | BRSK1 | 0.42217305 |
| 168 | CDK8 | 0.39551224 |
| 169 | MKNK2 | 0.39348685 |
| 170 | CSNK2A2 | 0.38062687 |
| 171 | PRKDC | 0.36212908 |
| 172 | RPS6KB1 | 0.34494815 |
| 173 | SIK3 | 0.33488510 |
| 174 | MAPK14 | 0.32671821 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.40225750 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.39636924 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.02838578 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.94968893 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92625972 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72928708 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.72335900 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.65557077 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.59523543 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54413833 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.51094553 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.50193208 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.48390570 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.37106334 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.30084763 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.28838405 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26681541 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.22355476 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.14933827 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13822692 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 2.10295430 |
| 22 | Cell cycle_Homo sapiens_hsa04110 | 2.09373832 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 2.03050120 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02578165 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00352592 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99386849 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.86237161 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.85019683 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.84804140 |
| 30 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.79644422 |
| 31 | Spliceosome_Homo sapiens_hsa03040 | 1.73358505 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.65746658 |
| 33 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.63690451 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.62376353 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.60133852 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.58113084 |
| 37 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.56740052 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.54103900 |
| 39 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48582531 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.46372603 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43882564 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43570885 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.41505328 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.39821269 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38959584 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.37949273 |
| 47 | Thyroid cancer_Homo sapiens_hsa05216 | 1.35667463 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.34003090 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32667145 |
| 50 | Adherens junction_Homo sapiens_hsa04520 | 1.32507360 |
| 51 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31625724 |
| 52 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29474849 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28892328 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 1.27330135 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.26723166 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.20478750 |
| 57 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18220720 |
| 58 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.16888909 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 1.09593119 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09097422 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.06882108 |
| 62 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.05203057 |
| 63 | Proteasome_Homo sapiens_hsa03050 | 1.05153201 |
| 64 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05037400 |
| 65 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04714129 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.03571202 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01715905 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00806143 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.95890182 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95684137 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94050523 |
| 72 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91593655 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.90804633 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90073251 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89937059 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88240063 |
| 77 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85916801 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81996321 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81467331 |
| 80 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.81178962 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.80073281 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77575918 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75950605 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74686920 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74402099 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73118725 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72857967 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72282907 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.71620444 |
| 90 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70809448 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70593845 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68312570 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.68222832 |
| 94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.66810260 |
| 95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66303167 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65130647 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63809743 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63671332 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63088510 |
| 100 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60062666 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58123093 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57891695 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57546135 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57162146 |
| 105 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54328982 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.52914549 |
| 107 | Protein export_Homo sapiens_hsa03060 | 0.51988622 |
| 108 | Prostate cancer_Homo sapiens_hsa05215 | 0.51925667 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.50740562 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.49287891 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48413831 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48323857 |
| 113 | Malaria_Homo sapiens_hsa05144 | 0.48310402 |
| 114 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47516306 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45920002 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.45374595 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.44459940 |
| 118 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44271358 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42078919 |
| 120 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.40163833 |
| 121 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39456095 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38311258 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38230076 |
| 124 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37737183 |
| 125 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37679280 |
| 126 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37040393 |
| 127 | Hepatitis B_Homo sapiens_hsa05161 | 0.37012424 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.36727461 |
| 129 | Purine metabolism_Homo sapiens_hsa00230 | 0.35533931 |
| 130 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32552266 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31691651 |
| 132 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31337831 |
| 133 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.31275701 |
| 134 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.29902334 |
| 135 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.29414279 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.28570999 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.28408089 |
| 138 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.25288471 |
| 139 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.25248732 |
| 140 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.23896938 |
| 141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20575126 |
| 142 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19172868 |
| 143 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.18553445 |
| 144 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17927810 |
| 145 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17358684 |
| 146 | Hepatitis C_Homo sapiens_hsa05160 | 0.17143865 |
| 147 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.17087007 |
| 148 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.17008448 |
| 149 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16767371 |
| 150 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16579587 |
| 151 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.15628047 |
| 152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15601317 |
| 153 | Measles_Homo sapiens_hsa05162 | 0.14819552 |
| 154 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14741645 |
| 155 | Pertussis_Homo sapiens_hsa05133 | 0.13879696 |
| 156 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.12708106 |
| 157 | Tuberculosis_Homo sapiens_hsa05152 | 0.12312203 |

